What the HbA1c test is and how it works
The HbA1c test (glycated haemoglobin or A1C) is a blood test that measures the percentage of haemoglobin bound to glucose in the bloodstream. Haemoglobin is the primary protein inside red blood cells responsible for transporting oxygen from the lungs throughout the body. When glucose circulates in the blood, a portion of it naturally and irreversibly binds to haemoglobin through a non-enzymatic process known as glycation. The higher the average concentration of glucose in the blood over preceding weeks, the greater the proportion of glycated haemoglobin, which the test reports as a single percentage [1, 2].
Red blood cells survive in the circulation for an average of approximately 120 days before being cleared and replaced by the body. Consequently, an HbA1c result provides a clinical summary of average blood glucose over the preceding two to three months. Recent weeks, particularly the past 30 days, have a greater effect on the result than earlier months. A substantial change in nutrition, physical activity, or treatment over recent weeks may therefore begin to appear in the result, although the test does not show an isolated temporary rise or fall [1, 2].
One major clinical advantage of the HbA1c test is that it does not require fasting. A blood sample can be drawn at any time of day regardless of recent food intake, because a meal consumed shortly before testing cannot immediately alter the stable glycation accumulated across preceding months. However, if a clinician orders the HbA1c alongside tests that require fasting, such as fasting plasma glucose or a full lipid panel, fasting instructions apply to those companion tests rather than the HbA1c itself [2, 10].
HbA1c ranges per ADA standards: normal, prediabetes, and diabetes
The American Diabetes Association (ADA) and international medical guidelines define precise diagnostic thresholds for interpreting HbA1c in non-pregnant adults. A result below 5.7% (below 39 mmol/mol) is classified as normal. Within this range, average systemic glucose exposure remains within physiological limits, and long-term microvascular risk is low. Routine screening in adults helps establish that metabolic regulation remains healthy [1, 2].
An HbA1c between 5.7% and 6.4% (39 to 47 mmol/mol) identifies prediabetes. This interval indicates that circulating glucose concentrations are consistently higher than normal but have not yet crossed the diagnostic threshold for established diabetes. A prediabetes result does not mean that progression is inevitable or that prescription medication must begin immediately. It is an opportunity to discuss practical lifestyle changes with a clinician, including balanced nutrition, more physical activity, and modest weight loss when appropriate; these changes can reduce the likelihood of progression to type 2 diabetes [1, 3]. Our dedicated guide on prediabetes HbA1c and medicine decisions explains when pharmacotherapy is considered, while our adult insulin-resistance assessment guide covers broader metabolic screening [1, 2].
An HbA1c result of 6.5% or higher (48 mmol/mol or higher) represents the diagnostic threshold for diabetes. Clinical guidelines specify that in an asymptomatic individual, an elevated result must be confirmed by repeating the test on a separate day (using either a repeat HbA1c or a fasting plasma glucose test) before formal diagnosis is established. Confirmation ensures that transient laboratory anomalies or acute stressors are not mistaken for chronic metabolic disease before initiating long-term management [1, 2, 10]. If the question is about a child, read about family meals for children with insulin resistance.
Translating the percentage into daily glucose numbers (eAG)
Patients often find percentage figures difficult to connect with the familiar mg/dL values displayed on home glucose meters. The landmark A1C-Derived Average Glucose (ADAG) study, endorsed by the ADA, established a validated mathematical relationship translating HbA1c into estimated average glucose (eAG). According to this formula, an HbA1c of 6.0% corresponds to an average glucose of approximately 126 mg/dL (7.0 mmol/L). Each subsequent 1% rise in HbA1c reflects an increase of roughly 28 to 30 mg/dL in estimated average circulating glucose [1, 4].
In routine clinical practice, these equivalents clarify what the percentage represents over 24-hour cycles: an HbA1c of 7.0% corresponds to approximately 154 mg/dL (8.6 mmol/L), while 8.0% translates to roughly 183 mg/dL (10.2 mmol/L). An HbA1c of 9.0% represents an average of 212 mg/dL (11.8 mmol/L), 10.0% reflects approximately 240 mg/dL (13.3 mmol/L), and 11.0% approaches 269 mg/dL (14.9 mmol/L). These numbers demonstrate that the laboratory result summarizes cumulative daytime postprandial surges and overnight levels, rather than a single isolated moment [1, 4].
Target HbA1c levels must be individualized rather than applied uniformly. For many non-pregnant adults with diabetes, an HbA1c goal below 7.0% is appropriate. A clinician may select a tighter goal when it can be reached safely without frequent or severe hypoglycaemia or other adverse effects of treatment. A less stringent goal (ADA gives below 8.0% as an example) may be appropriate when life expectancy is limited or when the harms and burdens of treatment outweigh its likely benefits. The target should therefore be agreed with the treating clinician for the individual, rather than treated as one number for everyone [1].
What causes falsely high or falsely low HbA1c results?
The accuracy of HbA1c depends partly on red blood cell turnover and haemoglobin characteristics. When a medical condition changes how red blood cells are produced or how long they remain in circulation, the result may not reflect glycaemia accurately. Studies have associated iron deficiency anaemia with higher HbA1c in some people, but the review literature states that the mechanism remains uncertain. Proposed explanations involve red blood cell turnover, cell characteristics, and the rate of haemoglobin glycation; they should not be presented as a settled mechanism applying to every patient [5, 6]. In a systematic review, most included studies found that HbA1c decreased after iron replacement, while one found an increase. Clinicians should therefore interpret HbA1c alongside glucose readings, a blood count, and iron studies rather than in isolation [6, 7].
Conversely, conditions that accelerate red blood cell turnover can produce falsely low HbA1c results. This may occur with haemolytic anaemia, acute blood loss, recovery after blood transfusion, or treatment with erythropoietin-stimulating agents. HbA1c can also be unreliable in advanced chronic kidney disease and during maintenance haemodialysis because red blood cell survival and other disease- and treatment-related factors are altered [5, 11, 12].
A third important category of interference involves inherited haemoglobin variants, including sickle haemoglobin (HbS) and haemoglobin C, D, or E. Their effect on the result depends on the variant and the assay method used. NGSP certification helps laboratories identify method-specific interference, but a clear mismatch between daily glucose readings and laboratory HbA1c should prompt clinical review of the assay and consideration of other monitoring approaches, such as fructosamine, glycated albumin, or continuous glucose monitoring (CGM) [5, 8, 9, 11, 12].
HbA1c during pregnancy: why it cannot be used alone
During pregnancy, physiological changes affect red blood cell turnover and the interpretation of HbA1c. Faster red blood cell turnover can make HbA1c lower than values seen outside pregnancy. The result therefore needs to be interpreted in the context of the stage of pregnancy and other glucose measurements, without assuming one fixed reference range for every pregnant person [1, 2, 5].
HbA1c should not be used by itself to diagnose gestational diabetes because it may not reveal post-meal hyperglycaemia. Diagnosis relies on the recommended glucose tests, including an oral glucose tolerance test (OGTT) at the appropriate stage of pregnancy. At the first prenatal visit, HbA1c may contribute to an assessment for diabetes that was present before pregnancy, according to the clinician's judgment [1, 2].
For people with diabetes that predates pregnancy, the ADA recommends an HbA1c goal below 6% if it can be achieved without significant hypoglycaemia. If necessary to prevent hypoglycaemia, the goal may be relaxed to below 7%. HbA1c does not replace daily meter or CGM readings, which show pre-meal and post-meal changes and help the treating clinician adjust care safely [1, 2].
How often to repeat the test, and what HbA1c does not show
The appropriate interval for repeating an HbA1c test depends directly on a patient's metabolic stability and clinical status. For individuals with diabetes who have achieved stable glycaemic control within their individualized target range, ADA standards recommend testing at least twice annually (every six months). Conversely, when glycaemic goals are not being met, or when pharmacological therapy has recently been initiated or adjusted, the test should be performed quarterly (every three months) to assess therapeutic efficacy. Individuals with prediabetes should be re-evaluated annually to monitor for disease progression, whereas asymptomatic adults with normal baseline screening and low metabolic risk require testing every three years [1, 2, 3].
Despite its value as a long-term measure, HbA1c is an average and may conceal important differences in daily glucose patterns. Two people can have the same HbA1c while experiencing different daily readings because the average does not show the timing of post-meal rises or episodes of hypoglycaemia. Meter or continuous glucose monitoring readings therefore matter when interpreting HbA1c [1, 12].
HbA1c also cannot show when glucose falls or quantify time spent within the target range (Time in Range). Comprehensive diabetes follow-up therefore uses more than periodic HbA1c testing. As explained in our comprehensive diabetes review beyond HbA1c guide, structured care may also include home glucose readings, blood pressure, kidney function, eye examinations, and neurological and foot checks according to individual need [1, 2, 10].
When symptoms require urgent care, and next steps with the medical team
Because an HbA1c value reflects long-term cumulative exposure, it is neither designed nor suitable for evaluating acute glycaemic emergencies. If an individual experiences severe acute symptoms (such as relentless extreme thirst, marked dehydration, persistent vomiting with inability to tolerate oral fluids, a distinct fruity breath odor, rapid deep breathing, profound fatigue, or altered mental status) these may signal diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS). These conditions are life-threatening medical emergencies that require immediate hospital emergency department evaluation, rather than waiting for an outpatient appointment or ordering an HbA1c [1, 2, 3].
Similarly, symptoms of severe hypoglycaemia require immediate intervention. Tremor, diaphoresis, palpitations, blurred vision, and cognitive confusion demand immediate fingerstick glucose verification and rapid-acting carbohydrate administration under the standard 15-15 rule (15 grams of fast-acting glucose, re-checking after 15 minutes). If confusion impairs safe swallowing or consciousness is lost, emergency services or glucagon administration must be mobilized immediately [1, 2].
Under routine circumstances, receiving an abnormal HbA1c result should never prompt self-adjustments of prescription medications or experimentation with unverified herbal remedies. The internal medicine team at La Rose provides structured metabolic assessments, correlating your HbA1c with daily lifestyle habits, home glucose dynamics, and cardiovascular and renal health to create a personalized, sustainable plan. La Rose welcomes patients at its Maadi and Fifth Settlement (New Cairo) branches for structured consultations designed to keep you safe and prevent long-term complications [1, 2, 3]. For non-urgent concerns, you can book a consultation with the medical team.
